{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T12:00:09Z","timestamp":1777896009253,"version":"3.51.4"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007129","name":"Shandong Province Natural Science Foundation","doi-asserted-by":"publisher","award":["ZR2020MH263"],"award-info":[{"award-number":["ZR2020MH263"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.bbrc.2026.153767","type":"journal-article","created":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T08:46:58Z","timestamp":1776242818000},"page":"153767","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Vindoline, a vinca alkaloid derived from Catharanthus roseus, targets ABCB1 to overcome docetaxel resistance in prostate cancer"],"prefix":"10.1016","volume":"818","author":[{"given":"Xulong","family":"Shao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruihui","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinyu","family":"Hou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yahan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenchang","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1366-9208","authenticated-orcid":false,"given":"Weiguo","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2026.153767_bib1","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1056\/NEJMoa2407934","article-title":"Assessment of a polygenic risk score in screening for prostate cancer","volume":"392","author":"McHugh","year":"2025","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbrc.2026.153767_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.eururo.2025.01.010","article-title":"Combination therapies in locally advanced and metastatic hormone-sensitive prostate cancer","author":"Azad","year":"2025","journal-title":"Eur. Urol."},{"key":"10.1016\/j.bbrc.2026.153767_bib3","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"Ca - Cancer J. Clin."},{"key":"10.1016\/j.bbrc.2026.153767_bib4","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.bbrc.2026.153767_bib5","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/S1470-2045(23)00230-9","article-title":"Which patients with metastatic hormone-sensitive prostate cancer benefit from docetaxel: a systematic review and meta-analysis of individual participant data from randomised trials","volume":"24","author":"Vale","year":"2023","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.bbrc.2026.153767_bib6","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.eururo.2024.11.013","article-title":"Recent patterns and trends in global prostate cancer incidence and mortality: an update","volume":"87","author":"Schafer","year":"2025","journal-title":"Eur. Urol."},{"key":"10.1016\/j.bbrc.2026.153767_bib7","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1038\/s41586-024-08290-3","article-title":"Evolution of myeloid-mediated immunotherapy resistance in prostate cancer","volume":"637","author":"Lyu","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2026.153767_bib8","article-title":"N6-methyladenosine-modified circQKI inhibits prostate cancer docetaxel-sensitivity via miR-188-3p\/Beclin-1 pathway","author":"Zhao","year":"2025","journal-title":"Life Sci."},{"key":"10.1016\/j.bbrc.2026.153767_bib9","article-title":"Prostate cancer: a review","author":"Raychaudhuri","year":"2025","journal-title":"JAMA"},{"key":"10.1016\/j.bbrc.2026.153767_bib10","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/pros.23946","article-title":"Docetaxel\u2010resistant prostate cancer cells become sensitive to gemcitabine due to the upregulation of ABCB1","volume":"80","author":"Seo","year":"2020","journal-title":"Prostate"},{"key":"10.1016\/j.bbrc.2026.153767_bib11","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s13046-025-03272-3","article-title":"AGD1\/USP10\/METTL13 complexes enhance cancer stem cells proliferation and diminish the therapeutic effect of docetaxel via CD44 m6A modification in castration resistant prostate cancer","volume":"44","author":"Wang","year":"2025","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.bbrc.2026.153767_bib12","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/s41419-024-06949-3","article-title":"Overcoming ABCB1 mediated multidrug resistance in castration resistant prostate cancer","volume":"15","author":"Sarwar","year":"2024","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbrc.2026.153767_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2025.101227","article-title":"TGF\u03b2-activated Asporin interacts with STMN1 to promote prostate cancer docetaxel chemoresistance and metastasis by upregulating the Wnt\/\u03b2-catenin signaling pathway","volume":"81","author":"Ge","year":"2025","journal-title":"Drug Resist. Updates"},{"key":"10.1016\/j.bbrc.2026.153767_bib14","article-title":"Mechanisms of docetaxel resistance in prostate cancer: the key role played by miRNAs","volume":"1875","author":"Rizzo","year":"2021","journal-title":"Biochim. Biophys. Acta Rev. Canc"},{"key":"10.1016\/j.bbrc.2026.153767_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114392","article-title":"Paclitaxel and docetaxel resistance in prostate cancer: molecular mechanisms and possible therapeutic strategies","volume":"160","author":"Hashemi","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bbrc.2026.153767_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2025.116749","article-title":"Cynanchum wallichii wight and CW1 reversed docetaxel resistance effects by inhibiting P-gp and promoting PI3K\/Akt-mediated apoptosis in prostate cancer","volume":"232","author":"Feng","year":"2025","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bbrc.2026.153767_bib17","doi-asserted-by":"crossref","first-page":"3249","DOI":"10.1111\/febs.17135","article-title":"ABCB 1\u2010mediated docetaxel resistance reversed by erastin in prostate cancer","volume":"291","author":"Chen","year":"2024","journal-title":"FEBS J."},{"key":"10.1016\/j.bbrc.2026.153767_bib18","first-page":"6026","article-title":"Overexpression of ABCB1 confers resistance to FLT3 inhibitor FN-1501 in cancer cells: in vitro and in vivo characterization","volume":"13","author":"Zhang","year":"2023","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.bbrc.2026.153767_bib19","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s12885-024-13371-7","article-title":"Preclinical studies of the falnidamol as a highly potent and specific active ABCB1 transporter inhibitor","volume":"25","author":"Liu","year":"2025","journal-title":"BMC Cancer"},{"key":"10.1016\/j.bbrc.2026.153767_bib20","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.869461","article-title":"Itraconazole reverts ABCB1-mediated docetaxel resistance in prostate cancer","volume":"13","author":"Lima","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bbrc.2026.153767_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2024.107099","article-title":"Natural products for combating multidrug resistance in cancer","volume":"202","author":"Chen","year":"2024","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bbrc.2026.153767_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2024.107167","article-title":"Natural compounds targeting YAP\/TAZ axis in cancer: current state of art and challenges","volume":"203","author":"Kumar","year":"2024","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bbrc.2026.153767_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2023.116405","article-title":"Natural bioactive compounds-doxorubicin combinations targeting topoisomerase II-alpha: anticancer efficacy and safety","volume":"461","author":"Elfadadny","year":"2023","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.bbrc.2026.153767_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13346-023-01389-6","article-title":"Vincristine-based nanoformulations: a preclinical and clinical studies overview","volume":"14","author":"Shukla","year":"2024","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.bbrc.2026.153767_bib25","doi-asserted-by":"crossref","first-page":"3775","DOI":"10.3390\/ijms26083775","article-title":"Synthesis and in vitro evaluation of the anticancer effect of novel phosphonium vindoline derivatives","volume":"26","author":"Halmai","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrc.2026.153767_bib26","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1007\/s00709-024-02026-w","article-title":"Vindoline is a key component of Catharanthus roseus leaf juice extract prepared through an Ayurveda-based method for ameliorating insulin-resistant type 2 diabetes","volume":"262","author":"Singh","year":"2025","journal-title":"Protoplasma"},{"key":"10.1016\/j.bbrc.2026.153767_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2023.107863","article-title":"Analyzing the molecular mechanism of xuefuzhuyu decoction in the treatment of pulmonary hypertension with network pharmacology and bioinformatics and verifying molecular docking","volume":"169","author":"Yu","year":"2024","journal-title":"Comput. Biol. Med."},{"key":"10.1016\/j.bbrc.2026.153767_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.foodchem.2024.141973","article-title":"The molecular reactive pathway between lipoxygenase and lipase and reactive species generated in dielectric barrier discharge atmospheric cold plasma: an investigation using molecular docking","volume":"465","author":"Wang","year":"2025","journal-title":"Food Chem."},{"key":"10.1016\/j.bbrc.2026.153767_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.113705","article-title":"Mechanism of dihydroartemisinin in the treatment of ischaemia\/reperfusion-induced acute kidney injury via network pharmacology, molecular dynamics simulation and experiments","volume":"144","author":"Jiang","year":"2025","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.bbrc.2026.153767_bib30","doi-asserted-by":"crossref","first-page":"313","DOI":"10.3389\/fonc.2019.00313","article-title":"Glesatinib, a c-MET\/SMO dual inhibitor, antagonizes P-glycoprotein mediated multidrug resistance in cancer cells","volume":"9","author":"Cui","year":"2019","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bbrc.2026.153767_bib31","doi-asserted-by":"crossref","first-page":"3263","DOI":"10.1016\/j.apsb.2022.03.023","article-title":"Preclinical studies of the triazolo [1, 5-a] pyrimidine derivative WS-716 as a highly potent, specific and orally active P-glycoprotein (P-gp) inhibitor","volume":"12","author":"Wang","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.bbrc.2026.153767_bib32","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s12943-022-01512-0","article-title":"PBK\/TOPK inhibitor OTS964 resistance is mediated by ABCB1-dependent transport function in cancer: in vitro and in vivo study","volume":"21","author":"Yang","year":"2022","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bbrc.2026.153767_bib33","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.micpath.2017.01.013","article-title":"Growth retardation induced by avian leukosis virus subgroup J associated with down-regulated Wnt\/\u03b2-catenin pathway","volume":"104","author":"Feng","year":"2017","journal-title":"Microb Pathog."},{"key":"10.1016\/j.bbrc.2026.153767_bib34","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/jcmm.17663","article-title":"Ribosomal protein L22\u2010like1 promotes prostate cancer progression by activating PI3K\/Akt\/mTOR signalling pathway","volume":"27","author":"Yi","year":"2023","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.bbrc.2026.153767_bib35","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.toxicon.2022.02.023","article-title":"Microcystin-LR induced microfilament rearrangement and cell invasion by activating ERK\/VASP\/ezrin pathway in DU145 cells","volume":"210","author":"Zhang","year":"2022","journal-title":"Toxicon"},{"key":"10.1016\/j.bbrc.2026.153767_bib36","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/s12964-022-00955-8","article-title":"Adagrasib, a KRAS G12C inhibitor, reverses the multidrug resistance mediated by ABCB1 in vitro and in vivo","volume":"20","author":"Zhang","year":"2022","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.bbrc.2026.153767_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13046-020-1537-9","article-title":"Reversal of ABCB1-related multidrug resistance by ERK5-IN-1","volume":"39","author":"Wang","year":"2020","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.bbrc.2026.153767_bib38","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/cac2.12040","article-title":"Modulating the function of ABCB1: in vitro and in vivo characterization of sitravatinib, a tyrosine kinase inhibitor","volume":"40","author":"Yang","year":"2020","journal-title":"Cancer Commun."},{"key":"10.1016\/j.bbrc.2026.153767_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12943-019-1112-1","article-title":"The PI3K subunits, P110\u03b1 and P110\u03b2 are potential targets for overcoming P-gp and BCRP-mediated MDR in cancer","volume":"19","author":"Zhang","year":"2020","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bbrc.2026.153767_bib40","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s12943-022-01524-w","article-title":"CDK6-PI3K signaling axis is an efficient target for attenuating ABCB1\/P-gp mediated multi-drug resistance (MDR) in cancer cells","volume":"21","author":"Zhang","year":"2022","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bbrc.2026.153767_bib41","doi-asserted-by":"crossref","first-page":"955","DOI":"10.3389\/fonc.2020.00955","article-title":"Erdafitinib antagonizes ABCB1-mediated multidrug resistance in cancer cells","volume":"10","author":"Feng","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bbrc.2026.153767_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.217355","article-title":"PAF1-mediated transcriptional reprogramming confers docetaxel resistance in advanced prostate cancer","volume":"609","author":"Muniyan","year":"2025","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbrc.2026.153767_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105954","article-title":"ABCB1 and ABCG2 limit brain penetration and, together with CYP3A4, total plasma exposure of abemaciclib and its active metabolites","volume":"178","author":"Martinez-Chavez","year":"2022","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bbrc.2026.153767_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2023.108488","article-title":"Strategies to overcome cancer multidrug resistance (MDR) through targeting P-glycoprotein (ABCB1): an updated review","volume":"249","author":"Dong","year":"2023","journal-title":"Pharmacol. Therapeut."},{"key":"10.1016\/j.bbrc.2026.153767_bib45","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1016\/j.apsb.2021.12.018","article-title":"MET inhibitor tepotinib antagonizes multidrug resistance mediated by ABCG2 transporter: in vitro and in vivo study","volume":"12","author":"Wu","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.bbrc.2026.153767_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.217309","article-title":"Mobocertinib antagonizes multidrug resistance in ABCB1-and ABCG2-overexpressing cancer cells: in vitro and in vivo studies","volume":"607","author":"Dong","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbrc.2026.153767_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.117603","article-title":"Gilteritinib reverses ABCB1-mediated multidrug resistance: preclinical in vitro and animal investigations","volume":"180","author":"Zhang","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bbrc.2026.153767_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114542","article-title":"Cancer multidrug-resistance reversal by ABCB1 inhibition: a recent update","volume":"239","author":"Engle","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bbrc.2026.153767_bib49","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jgr.2018.10.007","article-title":"Ginsenoside Rg5 overcomes chemotherapeutic multidrug resistance mediated by ABCB1 transporter: in vitro and in vivo study","volume":"44","author":"Feng","year":"2020","journal-title":"J. Ginseng. Res."},{"key":"10.1016\/j.bbrc.2026.153767_bib50","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/s41574-022-00745-9","article-title":"The ATP-binding cassette proteins ABCB1 and ABCC1 as modulators of glucocorticoid action","volume":"19","author":"Devine","year":"2023","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.bbrc.2026.153767_bib51","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.bcp.2019.05.015","article-title":"Tepotinib reverses ABCB1-mediated multidrug resistance in cancer cells","volume":"166","author":"Wu","year":"2019","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bbrc.2026.153767_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2024.101100","article-title":"Lansoprazole (LPZ) reverses multidrug resistance (MDR) in cancer through impeding ATP-binding cassette (ABC) transporter-mediated chemotherapeutic drug efflux and lysosomal sequestration","volume":"76","author":"Ji","year":"2024","journal-title":"Drug Resist. Updates"},{"key":"10.1016\/j.bbrc.2026.153767_bib53","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.574861","article-title":"Sapitinib reverses anticancer drug resistance in colon cancer cells overexpressing the ABCB1 transporter","volume":"10","author":"Gao","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bbrc.2026.153767_bib54","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/s41401-023-01151-1","article-title":"PGAM5 exacerbates acute renal injury by initiating mitochondria-dependent apoptosis by facilitating mitochondrial cytochrome c release","volume":"45","author":"Li","year":"2024","journal-title":"Acta Pharmacol. Sin."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X26005310?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X26005310?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T08:10:12Z","timestamp":1777623012000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X26005310"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":54,"alternative-id":["S0006291X26005310"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2026.153767","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vindoline, a vinca alkaloid derived from Catharanthus roseus, targets ABCB1 to overcome docetaxel resistance in prostate cancer","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2026.153767","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"153767"}}